论文部分内容阅读
目的：探讨Smad3 shRNA对CC14诱导的小鼠急性肝损伤的保护作用及其机制。方法：BALB/C小鼠尾静脉注射pGCsi-U6/Neo-Smad3 shRNA表达质粒或pGCsi-U6/Neo空质粒,12h后腹腔注射CC14及Olive建立肝损伤模型。
Smad3 shRNA对CCI4诱导小鼠急性肝损伤的保护作用
【摘 要】
：
目的：探讨Smad3 shRNA对CC14诱导的小鼠急性肝损伤的保护作用及其机制。方法：BALB/C小鼠尾静脉注射pGCsi-U6/Neo-Smad3 shRNA表达质粒或pGCsi-U6/Neo空质粒,12h后腹腔注射C
【机 构】
：
吉林大学基础医学院免疫学系 130021
【出 处】
：
中国免疫学会第十届全国免疫学学术大会
【发表日期】
：
2015年期
其他文献
Pegylated Interferon-α Followed by low-dose Interleukin-2 improves the anti-HBV Immunity for HBV non
Background: More than 60% of patients infected with hepatitis B virus (HBV) regarded as NR have a diminished HBV virologic response to standard interferon (
会议
Introduction: Currently Tuberculosis (TB) is still a serious public health challenge that contributes significantly to illness and death around the world.
会议
研究背景：人类T细胞白血病l型病毒(human T-cell leukemia virus type 1,HTLV-1)是30年前第一个被发现的可以感染人的逆转录病毒.HTLV-1病毒感染主要导致两类疾病的发生：成
Correlation between Fcγ receptor CD16 and Porcine Reproductive and Respiratory Syndrome Virus infect
会议
Comparison of cellular and humoral immunity between Influenza A/H1N1/2009 infected patients and vacc
Aim: The epidemic Influenza A/H1N1 in 2009 causes severe morbidity and mortality mainly in elder and children population.
会议
NKp30+ NK cells contribute to HBV control during Pegylated-interferon-alfa-2b therapy of chronic hep
Approximately 400 million people are chronic HBV surface antigen carriers.There is a pressing need to improve therapeutic options for chronic hepatitis B.Pe
会议
已知HBV感染后存在严重免疫耐受现象,但其机制知之甚少,我们根据本室多年研究结合资料分析,认为HBV的免疫耐受可能存在天然免疫耐受和诱导性免疫耐受两种机制.1、天然免
会议
背景：肝移植是目前治疗终末期肝病最有效的治疗方式，近年来随着外科学、影像学尤其是免疫抑制剂的应用，移植受者生存率获得了显著提高。但长期的免疫抑制剂如他克莫司(FK506
目的：心肌梗死后引起一系列炎症反应。大量炎症细胞向梗死区浸润并产生大量细胞因子，引起细胞死亡及心室重构。肌母细胞的具有免疫调节作用，能否用于心肌梗死的治疗，以及发挥
Cytotoxic T lymphocyte antigen-4 down-regulates T helper 1 cells by increasing STAT3 expression in a
Objective: The purpose of this study was to ascertain if cytotoxic T lymphocyte antigen-4 (CTLA-4) playing an important role in the occurrence and progress